263 related articles for article (PubMed ID: 20685681)
1. Of fads, fashion, surrogate endpoints and dual RAS blockade.
Messerli FH; Staessen JA; Zannad F
Eur Heart J; 2010 Sep; 31(18):2205-8. PubMed ID: 20685681
[TBL] [Abstract][Full Text] [Related]
2. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
Weir MR
Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
[TBL] [Abstract][Full Text] [Related]
3. [Blockade of the renin-angiotensin system by a combination of ACE inhibitors and AT1 receptor antagonists].
Azizi M
Rev Prat; 2004 Jun; 54(11):1167-74. PubMed ID: 15496022
[TBL] [Abstract][Full Text] [Related]
4. Recent changes in the landscape of combination RAS blockade.
Epstein BJ; Smith SM; Choksi R
Expert Rev Cardiovasc Ther; 2009 Nov; 7(11):1373-84. PubMed ID: 19900020
[TBL] [Abstract][Full Text] [Related]
5. Combined blockade of the renin-angiotensin system with angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists.
Azizi M; Ménard J
Circulation; 2004 Jun; 109(21):2492-9. PubMed ID: 15173039
[No Abstract] [Full Text] [Related]
6. Angiotensin II type 1 receptor blockade: high hopes sent back to reality?
Grothusen A; Divchev D; Luchtefeld M; Schieffer B
Minerva Cardioangiol; 2009 Dec; 57(6):773-85. PubMed ID: 19942847
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of the renin-angiotensin system, with particular reference to dual blockade treatment.
Andersen NH; Mogensen CE
J Renin Angiotensin Aldosterone Syst; 2001 Sep; 2(3):146-52. PubMed ID: 11881115
[No Abstract] [Full Text] [Related]
8. Dual blockade of the renin-angiotensin system in diabetic nephropathy.
Wade VL; Gleason BL
Ann Pharmacother; 2004; 38(7-8):1278-82. PubMed ID: 15187210
[TBL] [Abstract][Full Text] [Related]
9. Effect of renin-angiotensin system blockade on calcium channel blocker-associated peripheral edema.
Makani H; Bangalore S; Romero J; Wever-Pinzon O; Messerli FH
Am J Med; 2011 Feb; 124(2):128-35. PubMed ID: 21295192
[TBL] [Abstract][Full Text] [Related]
10. Renin Angiotensin Aldosterone System Blockade: Little to No Rationale for ACE Inhibitor and ARB Combinations.
Holdiness A; Monahan K; Minor D; de Shazo RD
Am J Med; 2011 Jan; 124(1):15-9. PubMed ID: 21187182
[TBL] [Abstract][Full Text] [Related]
11. Effect of renin-angiotensin-aldosterone system triple blockade on non-diabetic renal disease: addition of an aldosterone blocker, spironolactone, to combination treatment with an angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker.
Furumatsu Y; Nagasawa Y; Tomida K; Mikami S; Kaneko T; Okada N; Tsubakihara Y; Imai E; Shoji T
Hypertens Res; 2008 Jan; 31(1):59-67. PubMed ID: 18360019
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the effects of angiotensin receptor antagonist, angiotensin converting enzyme inhibitor, and their combination on regression of left ventricular hypertrophy of diabetes type 2 patients on recent onset hemodialysis therapy.
Suzuki H; Kanno Y; Kaneko K; Kaneko M; Kotaki S; Mimura T; Takane H
Ther Apher Dial; 2004 Aug; 8(4):320-7. PubMed ID: 15274684
[TBL] [Abstract][Full Text] [Related]
13. [Renin-angiotensin system as a potential target for the treatment with heart failure: ACE inhibitors, angiotensin-II receptor blockers and aldosterone antagonists].
Sanada S; Kitakaze M
Nihon Rinsho; 2003 May; 61(5):821-6. PubMed ID: 12755009
[TBL] [Abstract][Full Text] [Related]
14. Dual renin angiotensin system blockade in patients with acute myocardial infarction and preserved left ventricular systolic function.
Suşan M; Petrescu L; Riviş AI; Suşan RM; Burghină D; Dan R; Cozma D; Drăgulescu SI
Rom J Intern Med; 2005; 43(3-4):187-98. PubMed ID: 16812979
[TBL] [Abstract][Full Text] [Related]
15. Blocking the renin-angiotensin system: dual- versus mono-therapy.
Ravandi A; Teo KK
Expert Rev Cardiovasc Ther; 2009 Jun; 7(6):667-74. PubMed ID: 19505282
[TBL] [Abstract][Full Text] [Related]
16. The sudden demise of dual renin-angiotensin system blockade or the soft science of the surrogate end point.
Messerli FH
J Am Coll Cardiol; 2009 Feb; 53(6):468-70. PubMed ID: 19195602
[TBL] [Abstract][Full Text] [Related]
17. The role of renin inhibition in treating the hypertensive patient with diabetes: a summary of preclinical and clinical evidence.
Abdellatif AA
Expert Rev Cardiovasc Ther; 2012 Feb; 10(2):251-63. PubMed ID: 22292880
[TBL] [Abstract][Full Text] [Related]
18. Advantages of renin-angiotensin system blockade in the treatment of cardiovascular diseases.
Gerc V; Buksa M
Med Arh; 2010; 64(5):295-9. PubMed ID: 21287956
[TBL] [Abstract][Full Text] [Related]
19. Addition of an angiotensin receptor blocker to full-dose ACE-inhibition: controversial or common sense?
van de Wal RM; van Veldhuisen DJ; van Gilst WH; Voors AA
Eur Heart J; 2005 Nov; 26(22):2361-7. PubMed ID: 16105846
[TBL] [Abstract][Full Text] [Related]
20. [Is there still a place for a dual blockade of the renin-angiotensin system in 2012?].
Krzesinski JM; Scheen AJ
Rev Med Suisse; 2012 Aug; 8(351):1598-603. PubMed ID: 22988713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
